Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: ODTX) Delayed: 20.51 --0 (-0%)
Previous Close $20.51    52 Week High $ 
Open $20.51    52 Week Low $ 
Day High $20.51    P/E N/A 
Day Low $20.51    EPS $ 
Volume 8